Recent studies have indicated that the disease-associated fusion protein EWS-FLI1 activates or inhibits enhancer elements in Ewing sarcoma through different chromatin remodeling patterns (Riggi et al., 2014; Tomazou et al., 2015). This evidence concerns the gene FLI1 and Ewing sarcoma.